We are live on ! Find out more
PTCT icon

PTC Therapeutics
PTCT

115 hedge funds and large institutions have $310M invested in PTC Therapeutics in 2017 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 34

7.67% more ownership

Funds ownership: 83.56% → 91.23% (+7.7%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 27

1% less capital invested

Capital invested by funds: $313M → $310M (-$2.68M)

9% less call options, than puts

Call options by funds: $15.1M | Put options by funds: $16.5M

7% less funds holding

Funds holding: 123 → 115 (-8)

Holders
115
Holders Change
-8
Holders Change %
-6.5%
% of All Funds
2.86%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
27
Increased
38
Reduced
34
Closed
27
Calls
$15.1M
Puts
$16.5M
Net Calls
-$1.42M
Net Calls Change
-$11.4M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$38.8M
2
BC
Boxer Capital
California
+$18.2M
3
GPP
Great Point Partners
Connecticut
+$17.8M
4
State Street
State Street
Massachusetts
+$15.8M
5
CCM
Camber Capital Management
Massachusetts
+$15.1M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$30.3M
2
Millennium Management
Millennium Management
New York
-$9.53M
3
TAM
Tocqueville Asset Management
New York
-$8.84M
4
JP Morgan Chase
JP Morgan Chase
New York
-$6.76M
5
SA
Sicart Associates
New York
-$4.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$2.94M +$2.63M +217,192 +266%
PCM
27
Prelude Capital Management
New York
$2.92M +$1.39M +115,171 +64%
KCM
28
Kingdon Capital Management
New York
$2.81M -$3.87M -319,716 -53%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$2.66M +$133K +10,958 +4%
QI
30
QS Investors
New York
$2.31M +$115K +9,468 +4%
Group One Trading
31
Group One Trading
Illinois
$2.22M +$1.79M +147,865 +190%
GTC
32
Ghost Tree Capital
New York
$1.97M +$2.42M +200,000 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.79M +$244K +20,123 +12%
SDIC
34
South Dakota Investment Council
South Dakota
$1.78M – – –
CWG
35
C WorldWide Group
Denmark
$1.56M +$162K +13,364 +9%
CCI
36
Columbus Circle Investors
$1.56M +$597K +49,316 +45%
Charles Schwab
37
Charles Schwab
California
$1.24M +$82.8K +6,840 +6%
CS
38
Credit Suisse
Switzerland
$1.02M +$580K +47,955 +87%
HT
39
HAP Trading
New York
$1M +$1.23M +101,707 New
MCM
40
Moore Capital Management
New York
$984K +$605K +50,000 +100%
TCIM
41
TIAA CREF Investment Management
New York
$948K +$33.6K +2,774 +3%
Fisher Asset Management
42
Fisher Asset Management
Washington
$882K +$21.8K +1,800 +2%
ARTA
43
A.R.T. Advisors
New York
$874K -$446K -36,811 -29%
Barclays
44
Barclays
United Kingdom
$759K +$640K +52,869 +217%
Morgan Stanley
45
Morgan Stanley
New York
$742K -$2.66M -219,780 -74%
Connor, Clark & Lunn Investment Management (CC&L)
46
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$717K +$882K +72,825 New
Deutsche Bank
47
Deutsche Bank
Germany
$685K -$4.03M -333,250 -83%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$645K -$35.1K -2,900 -4%
Wells Fargo
49
Wells Fargo
California
$625K -$99.4K -8,209 -11%
AllianceBernstein
50
AllianceBernstein
Tennessee
$615K -$85.9K -7,100 -10%
1
2
3 4 5

PTCT Hedge Fund Activity: Q1 2017 in Review

115 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q1 2017, worth a combined $310M — down 0.86% from $313M a quarter earlier.

Fund positioning in PTCT was balanced in Q1 2017: 27 funds opened new positions, 27 closed out, 38 added to existing stakes and 34 trimmed.

The largest buyer was BlackRock, adding an estimated $38.8M. The largest seller was Wellington Management Group, cutting an estimated $30.3M.

  • 115 institutional investors held PTC Therapeutics (PTCT) as of Q1 2017, down from 123 in Q4 2016.
  • Funds reported $310M of PTC Therapeutics stock for Q1 2017, down 0.86% quarter-over-quarter.
  • 27 funds opened new PTC Therapeutics positions in Q1 2017 and 27 closed out, a net change of 0 holders.
  • The largest PTC Therapeutics buyer in Q1 2017 was BlackRock, an estimated $38.8M added.
  • The largest PTC Therapeutics seller in Q1 2017 was Wellington Management Group, an estimated $30.3M sold.

Based on aggregated 13F filings for Q1 2017.